Linköping, Sweden [November 12, 2018] AMRA has now published a White Paper providing insights about the link between specific fat distributions and metabolic diseases. Body composition and fat distribution is an unknown factor in many clinical trials conducted in the metabolic area today. Many studies are likely conducted in a population thought to be homogeneous, while those studies actually include subjects with vastly different body compositions associated with completely different metabolic disease profiles. The answer to whom should be included and which subjects respond best to a treatment could lie in body composition.

Click here to read the White Paper